Standards; Pharmaceutical/API Drug Impurities/Metabolites;
應(yīng)用:
Ibrutinib Addition Adduct with (R)-1-(3-(4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl) is an impurity of Ibrutinib (I124970), which is a immunotherapeutic drug used to target B cell receptor signaling and can possibly inhibit Wnt signaling.
?您的位置：![Ibrutinib Addition Adduct with (R)-1-(3-(4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyr](/uploads/allimg/191211/1_1211032110B38.png "Ibrutinib Addition Adduct with (R)-1-(3-(4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyr")
